A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5

Clinical trial NCT05585567 · UNKNOWN

Trial details

NCT number: NCT05585567
Sponsor: Livzon Pharmaceutical Group Inc.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

COVID-19 Pandemic

Start date: 2022-09-16
Primary completion: 2022-10-14
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.